Comparing two radiation therapies for a rare brain tumor
Part of Brain & nervous system, Cancer clinical trials.
This trial compares two types of radiation therapy for children with diffuse intrinsic pontine glioma (DIPG), a rare brain tumor. It aims to see which treatment may be more effective while helping you understand your options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 3 and 18 years old.
- You must have a confirmed diagnosis of a specific type of brain tumor (DIPG) via biopsy.
- You should be in generally good health (able to carry out daily activities).
- You must not have had radiation to the head before.
- Your blood counts and organ function must be within acceptable ranges.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the drug ACT001 in people with a type of brain tumor called DIPG or other related high-grade gliomas. It aims to see if the drug can help control the tumor and improve outcomes.
This trial tests whether adding antineoplaston therapy (a substance that may slow cancer cell growth) to standard radiation helps people with a type of brain tumor called diffuse intrinsic pontine glioma (DIPG). It aims to see if the combination improves outcomes compared to radiation alone.
This trial tests if a precise type of radiation called proton therapy is safe and effective for children with certain brain tumors. It aims to reduce side effects by focusing radiation only on the tumor.
This trial tests whether adding sonodynamic therapy (a treatment that uses sound waves to activate a drug) before standard radiation and chemotherapy can help people with a type of brainstem glioma called DIPG. The goal is to see if this combination improves survival.
This trial is testing how well two different radiation techniques, IMPT and IMRT, work for treating breast cancer. It aims to see which one is safer and more effective, so you might benefit from a potentially better treatment approach.
This trial studies a targeted medicine approach for high-grade glioma (a fast-growing brain tumor) and some diffuse midline tumors, including DIPG. It may help by matching treatment to tumor biology using tumor testing done before or around starting standard therapy.
Hear when a new Diffuse Intrinsic Pontine Gliomas (DIPG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.